ProfTriona Ni Chonghaile
Associate Professor
Physiology and Medical Physics
- Associate ProfessorPhysiology and Medical Physics
- 4028579 (Work)
- RCSI, Physiology & Medical Physics, 123 St Stephens Green, Dublin 2
RESEARCH OVERVIEW
Lab Overview: Targeted Therapeutics in Cancer (TTC Lab)
The TTC Lab investigates cell death signalling pathways, with a particular emphasis on the BCL-2 family of proteins that regulate mitochondrial apoptosis. Using advanced techniques such as BH3 profiling, the team measures cellular sensitivity to apoptosis and dependence on anti-apoptotic proteins. This work has been featured in high-impact publications including:
- Walsh et al., Clinical Cancer Research (2019)
- Di Grande et al., Blood Advances (2021)
- Sullivan et al., Science Translational Medicine (2022)
- Flanagan et al., Hematologica (2024)
In a recent breakthrough, the lab identified a novel, specific inhibitor of histone deacetylase 6 (HDAC6) through a screen for compounds that target apoptosis-resistant cancer cells. This discovery unveiled a previously unknown role for HDAC6 in tumour cell metabolism, leading to a US patent application (No. 63/125,759) and publications in:
- Dowling et al., Science Advances (2021)
- Roe et al., Nature Communications (2025)
- Rodrigues et al., Nature communications (2026)
Building on their HDAC6 research, the team has developed a PROTAC-based therapeutic derived from their original small molecule inhibitor. This promising compound holds potential for future clinical development and licensing.
GRANTS
- FUNDED PROJECTStudent Selected Projects (SSP) 2027RCSI1 Oct 2026 - 30 Sep 2027
- FUNDED PROJECTPrecision Oncology Ireland 2.0 (POI2) – WP 2.1A: Modelling childhood cancers from bench to bedsideChildren’s Health Foundation1 Oct 2025 - 30 Sep 2030
- FUNDED PROJECTPrecision Oncology Ireland-2 (POI2)Research Ireland1 Oct 2025 - 30 Sep 2030
- FUNDED PROJECTPrecision Oncology Ireland-2 (POI2)Research Ireland1 Oct 2025 - 30 Sep 2030
- FUNDED PROJECTPrecision Oncology Ireland-2 (POI2) Doctoral Training Program (DTP)Research Ireland1 Oct 2025 - 30 Sep 2030
- FUNDED PROJECTResearch Ireland (formerly IRC) 2025 Supplementary StipendResearch Ireland1 Jan 2025 - 31 Dec 2025
- FUNDED PROJECTResearch Ireland (formerly SFI) 2025 Supplementary StipendResearch Ireland1 Jan 2025 - 31 Dec 2025
- FUNDED PROJECTRCSI-Fulbright Joint PhD Programme 2024 CohortRCSI1 Sep 2024 - 30 Sep 2028
- FUNDED PROJECTStudent Selected Projects (SSP) 2024RCSI29 Apr 2024 - 28 Apr 2025
- FUNDED PROJECTCommercialisation of a Histone deacetylase 6 PROTACEnterprise Ireland25 Mar 2024 - 31 Aug 2024
- FUNDED PROJECTSFI PhD 2024 Additional Stipend AllowanceScience Foundation Ireland (SFI)1 Jan 2024 - 31 Dec 2024
- FUNDED PROJECTStipend increase for non state-funded PhD scholarsRCSI1 Jan 2024 - 30 Sep 2029
- FUNDED PROJECTHEA Support for COVID-19 Related Research Costed ExtensionsHigher Education Authority1 Sep 2023 - 30 Nov 2024
- FUNDED PROJECTStudent Selected Projects (SSP) 2023RCSI5 Jan 2023 - 30 Sep 2025
- FUNDED PROJECTRCSI International Secondment Awards 2022RCSI26 Sep 2022 - 31 Dec 2023
- FUNDED PROJECTDynamics of ageing and cancer: a multi-functional study into apoptosis, metabolism and the microenvironment - Ageing-MMIrish Research Council IRC1 Sep 2022 - 30 Jun 2027
- FUNDED PROJECTMedicinal chemistry approaches to make atypical HDAC6 inhibitors and PROTACs to treat Multiple MyelomaRCSI1 Sep 2022 - 31 Aug 2023
- FUNDED PROJECTMedicinal chemistry approaches to make atypical HDAC6 inhibitors and PROTACs to treat Multiple MyelomaIrish Research Council IRC1 Sep 2022 - 31 Aug 2023
- FUNDED PROJECTMM_BH3_CutTagEU Horizon Europe1 Sep 2022 - 14 Apr 2024
- FUNDED PROJECTStudent Selected Projects (SSP) 2022RCSI16 May 2022 - 15 May 2023
- FUNDED PROJECTDefining the pro-survival signalling of the bone marrow microenvironment of multiple myelomaIrish Cancer Society11 Oct 2021 - 11 Apr 2027
- FUNDED PROJECTStAR International PhD Programme 2021RCSI27 Aug 2021 - 30 Sep 2027
- FUNDED PROJECTIn depth-characterisation of the role of splenic microenvironment in the development of ABT-199 resistanceRCSI1 Oct 2020 - 30 Sep 2021
- FUNDED PROJECTIn depth-characterisation of the role of splenic microenvironment in the development of ABT-199 resistanceIrish Research Council IRC1 Oct 2020 - 30 Sep 2021
- FUNDED PROJECTSplen-DIDEnterprise Ireland H2020 Support18 Sep 2020 - 17 Sep 2021